Given the critical nature of pricing strategy development in commercialization
of innovative new health care technologies, tJûn17 Life Sciences will leverage
its relationships with hundreds of stakeholders, including global public and
private payers, hospital administrators, sales and marketing personnel and
health economists. In doing so, we use a number of quantitative and qualitative
techniques to develop and optimize pricing strategy.
Some of our pricing analysis methodologies include the following analytic techniques:
In order to compete successfully in today’s global healthcare environment, manufacturers must design, develop and commercialize innovative new technologies. However, as any manufacturer knows, innovation comes at what sometimes are tremendously expensive costs.